Evidence map›Paper›PMID 24586527›Full record

ArticlePloS one2014

Pediatric malignancies, treatment outcomes and abandonment of pediatric cancer treatment in Zambia.

Jeremy S Slone, Catherine Chunda-Liyoka, Marta Perez, Nora Mutalima, Robert Newton, Chifumbe Chintu, Chipepo Kankasa, James Chipeta, Douglas C Heimburger, Sten H Vermund and 1 more

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Barriers to Radiotherapy Access in Sub-Saharan Africa for Patients with Cancer: A Systematic Review.International journal of environmental research and public health · 2024
    Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jeremy S SloneDivision of Pediatric Hematology-Oncology, Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Catherine Chunda-LiyokaDepartment of Pediatrics and Child Health, University Teaching Hospital, and University of Zambia School of Medicine, Lusaka, Zambia.
Marta PerezVanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Nora MutalimaEpidemiology and Cancer Statistics Group, University of York, York, England, United Kingdom.
Robert NewtonEpidemiology and Cancer Statistics Group, University of York, York, England, United Kingdom ; Medical Research Council/Uganda Virus Research Institute Research Unit on Acquired Immune Deficiency Syndrome (AIDS), Entebbe, Uganda.
Chifumbe ChintuDepartment of Pediatrics and Child Health, University Teaching Hospital, and University of Zambia School of Medicine, Lusaka, Zambia.
Chipepo KankasaDepartment of Pediatrics and Child Health, University Teaching Hospital, and University of Zambia School of Medicine, Lusaka, Zambia.
James ChipetaDepartment of Pediatrics and Child Health, University Teaching Hospital, and University of Zambia School of Medicine, Lusaka, Zambia.
Douglas C HeimburgerDivision of General Internal Medicine and Public Health, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America ; Vanderbilt Institute for Global Health, Nashville, Tennessee, United States of America.
Sten H VermundDivision of General Internal Medicine and Public Health, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America ; Vanderbilt Institute for Global Health, Nashville, Tennessee, United States of America ; Division of Pediatric Infectious Diseases, Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Debra L FriedmanDivision of Pediatric Hematology-Oncology, Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America ; Vanderbilt-Ingram Cancer Center; Nashville, Tennessee, United States of America.

Funding

Conducting Child Health Care Research in Vulnerable PopulationsT32HD060554 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BARKIN, SHARI, WILLIAMS, DEREK J. · 2009 to 2019
$3.8M
Cancer Research UKNICHD NIH HHS NIH 5 T32 HD 60554-3NICHD NIH HHS T32 HD060554
6 · The paper itself

Abstract

backgroundThere exist significant challenges to the receipt of comprehensive oncologic treatment for children diagnosed with cancer in sub-Saharan Africa. To better define those challenges, we investigated treatment outcomes and risk factors for treatment abandonment in a cohort of children diagnosed with cancer at the University Teaching Hospital (UTH), the site of the only pediatric oncology ward in Zambia.

methodsUsing an established database, a retrospective cohort study was conducted of children aged 0-15 years admitted to the pediatric oncology ward between July 2008 and June 2010 with suspected cancer. Diagnosis, mode of diagnosis, treatment outcome, and risk factors for abandonment of treatment were abstracted from this database and clinical medical records.

resultsAmong 162 children treated at the UTH during the study time period that met inclusion criteria, only 8.0% completed a treatment regimen with most of the patients dying during treatment or abandoning care. In multivariable analysis, shorter distance from home to the UTH was associated with a lower risk of treatment abandonment (Adjusted Odds Ratio [aOR]  = 0.48 (95% confidence interval [CI] 0.23-0.97). Conversely maternal education less than secondary school was associated with increased risk for abandonment (aOR = 1.65; 95% CI 1.05-2.58).

conclusionsDespite availability of dedicated pediatric oncology treatment, treatment completion rates are poor, due in part to the logistical challenges faced by families, low educational status, and significant distance from the hospital. Alternative treatment delivery strategies are required to bring effective pediatric oncology care to the patients in need, as their ability to come to and remain at a central tertiary care facility for treatment is limited. We suggest that the extensive system now in place in most of sub-Saharan Africa that sustains life-long antiretroviral therapy for children with human immunodeficiency virus (HIV) infection be adapted for pediatric cancer treatment to improve outcome.

Indexed as

AdolescentChildChild, PreschoolCohort StudiesHumansInfantInfant, NewbornNeoplasmsOdds RatioPatient DropoutsRetrospective StudiesRisk FactorsTreatment OutcomeZambia

Identifiers

PMID24586527
PMCPMC3931678

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.